Literature DB >> 23671278

CD163 binding to haptoglobin-hemoglobin complexes involves a dual-point electrostatic receptor-ligand pairing.

Marianne Jensby Nielsen1, Christian Brix Folsted Andersen, Søren Kragh Moestrup.   

Abstract

Formation of the haptoglobin (Hp)-hemoglobin (Hb) complex in human plasma leads to a high affinity recognition by the endocytic macrophage receptor CD163. A fast segregation of Hp-Hb from CD163 occurs at endosomal conditions (pH <6.5). The ligand binding site of CD163 has previously been shown to involve the scavenger receptor cysteine-rich (SRCR) domain 3. This domain and the adjacent SRCR domain 2 of CD163 contain a consensus motif for a calcium-coordinated acidic amino acid triad cluster as originally identified in the SRCR domain of the scavenger receptor MARCO. Here we show that site-directed mutagenesis in each of these acidic triads of SRCR domains 2 and 3 abrogates the high affinity binding of recombinant CD163 to Hp-Hb. In the ligand, Hp Arg-252 and Lys-262, both present in a previously identified CD163 binding loop of Hp, were revealed as essential residues for the high affinity receptor binding. These findings are in accordance with pairing of the calcium-coordinated acidic clusters in SRCR domains 2 and 3 with the two basic Arg/Lys residues in the Hp loop. Such a two-point electrostatic pairing is mechanistically similar to the pH-sensitive pairings disclosed in crystal structures of ligands in complex with tandem LDL receptor repeats or tandem CUB domains in other endocytic receptors.

Entities:  

Keywords:  Calcium-binding Proteins; Hemoglobin; Ligand-binding protein; Receptor Endocytosis; Scavenger Receptor

Mesh:

Substances:

Year:  2013        PMID: 23671278      PMCID: PMC3696659          DOI: 10.1074/jbc.M113.471060

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  CD163-L1 is an endocytic macrophage protein strongly regulated by mediators in the inflammatory response.

Authors:  Jesper B Moeller; Marianne J Nielsen; Martin P Reichhardt; Anders Schlosser; Grith L Sorensen; Ole Nielsen; Ida Tornøe; Jørn Grønlund; Maria E Nielsen; Jan S Jørgensen; Ole N Jensen; Jan Mollenhauer; Søren K Moestrup; Uffe Holmskov
Journal:  J Immunol       Date:  2012-01-25       Impact factor: 5.422

Review 2.  Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy.

Authors:  Hanne Van Gorp; Peter L Delputte; Hans J Nauwynck
Journal:  Mol Immunol       Date:  2010-03-17       Impact factor: 4.407

3.  Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding.

Authors:  Holger Jon Møller; Marianne Jensby Nielsen; Maciej Bogdan Maniecki; Mette Madsen; Søren Kragh Moestrup
Journal:  Immunobiology       Date:  2009-07-05       Impact factor: 3.144

Review 4.  The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis.

Authors:  Vanesa Gabriela Martínez; Søren Kragh Moestrup; Uffe Holmskov; Jan Mollenhauer; Francisco Lozano
Journal:  Pharmacol Rev       Date:  2011-08-31       Impact factor: 25.468

5.  Structure of the haptoglobin-haemoglobin complex.

Authors:  Christian Brix Folsted Andersen; Morten Torvund-Jensen; Marianne Jensby Nielsen; Cristiano Luis Pinto de Oliveira; Hans-Petter Hersleth; Niels Højmark Andersen; Jan Skov Pedersen; Gregers Rom Andersen; Søren Kragh Moestrup
Journal:  Nature       Date:  2012-08-26       Impact factor: 49.962

6.  Cloning of a novel scavenger receptor cysteine-rich type I transmembrane molecule (M160) expressed by human macrophages.

Authors:  J Gronlund; L Vitved; M Lausen; K Skjodt; U Holmskov
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

Review 7.  CD163 and inflammation: biological, diagnostic, and therapeutic aspects.

Authors:  Anders Etzerodt; Søren K Moestrup
Journal:  Antioxid Redox Signal       Date:  2012-10-19       Impact factor: 8.401

Review 8.  Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging.

Authors:  Marianne Jensby Nielsen; Søren Kragh Moestrup
Journal:  Blood       Date:  2009-04-20       Impact factor: 22.113

Review 9.  Hemoglobin and heme scavenger receptors.

Authors:  Marianne Jensby Nielsen; Holger Jon Møller; Søren Kragh Moestrup
Journal:  Antioxid Redox Signal       Date:  2010-02       Impact factor: 8.401

10.  Plasma clearance of hemoglobin and haptoglobin in mice and effect of CD163 gene targeting disruption.

Authors:  Anders Etzerodt; Mads Kjolby; Marianne Jensby Nielsen; Maciej Maniecki; Pia Svendsen; Søren Kragh Moestrup
Journal:  Antioxid Redox Signal       Date:  2012-08-29       Impact factor: 8.401

View more
  24 in total

1.  Haptoglobin Is a Divergent MASP Family Member That Neofunctionalized To Recycle Hemoglobin via CD163 in Mammals.

Authors:  Anthony K Redmond; Yuko Ohta; Michael F Criscitiello; Daniel J Macqueen; Martin F Flajnik; Helen Dooley
Journal:  J Immunol       Date:  2018-09-07       Impact factor: 5.422

2.  The class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophages.

Authors:  Fabian C Verbij; Nicoletta Sorvillo; Paul H P Kaijen; Johana Hrdinova; Ivan Peyron; Rob Fijnheer; Anja Ten Brinke; Alexander B Meijer; Floris P J van Alphen; Timo K van den Berg; Jonas J H Graversen; Soren K Moestrup; Jan Voorberg
Journal:  Blood Adv       Date:  2017-01-16

3.  Wnt7a induces a unique phenotype of monocyte-derived macrophages with lower phagocytic capacity and differential expression of pro- and anti-inflammatory cytokines.

Authors:  Jennillee Wallace; Victoria Lutgen; Sreedevi Avasarala; Brad St Croix; Robert A Winn; Lena Al-Harthi
Journal:  Immunology       Date:  2017-10-12       Impact factor: 7.397

4.  Interactions of ferritin with scavenger receptor class A members.

Authors:  Bowen Yu; Chen Cheng; Yichun Wu; Luqiang Guo; Dandan Kong; Ze Zhang; Yuanyuan Wang; Enlin Zheng; Yingbin Liu; Yongning He
Journal:  J Biol Chem       Date:  2020-09-09       Impact factor: 5.157

5.  The haptoglobin beta subunit sequesters HMGB1 toxicity in sterile and infectious inflammation.

Authors:  H Yang; H Wang; Y Wang; M Addorisio; J Li; M J Postiglione; S S Chavan; Y Al-Abed; D J Antoine; U Andersson; K J Tracey
Journal:  J Intern Med       Date:  2017-05-31       Impact factor: 8.989

6.  Macrophage-specific nanotechnology-driven CD163 overexpression in human macrophages results in an M2 phenotype under inflammatory conditions.

Authors:  Perla Abigail Alvarado-Vazquez; Laura Bernal; Candler A Paige; Rachel L Grosick; Carolina Moracho Vilrriales; David Wilson Ferreira; Cristina Ulecia-Morón; E Alfonso Romero-Sandoval
Journal:  Immunobiology       Date:  2017-05-16       Impact factor: 3.144

7.  Wild-type macrophages reverse disease in heme oxygenase 1-deficient mice.

Authors:  Gennadiy Kovtunovych; Manik C Ghosh; Wade Ollivierre; R Patrick Weitzel; Michael A Eckhaus; John F Tisdale; Akihiro Yachie; Tracey A Rouault
Journal:  Blood       Date:  2014-06-24       Impact factor: 22.113

8.  The Staphylococcus aureus Protein IsdH Inhibits Host Hemoglobin Scavenging to Promote Heme Acquisition by the Pathogen.

Authors:  Kirstine Lindhardt Sæderup; Kristian Stødkilde; Jonas Heilskov Graversen; Claire F Dickson; Anders Etzerodt; Søren Werner Karlskov Hansen; Angela Fago; David Gell; Christian Brix Folsted Andersen; Søren Kragh Moestrup
Journal:  J Biol Chem       Date:  2016-09-28       Impact factor: 5.157

9.  Structure-function analyses reveal key features in Staphylococcus aureus IsdB-associated unfolding of the heme-binding pocket of human hemoglobin.

Authors:  Catherine F M Bowden; Anson C K Chan; Emily J W Li; Angelé L Arrieta; Lindsay D Eltis; Michael E P Murphy
Journal:  J Biol Chem       Date:  2017-11-06       Impact factor: 5.157

10.  Structural basis for inflammation-driven shedding of CD163 ectodomain and tumor necrosis factor-α in macrophages.

Authors:  Anders Etzerodt; Mie Rostved Rasmussen; Pia Svendsen; Athena Chalaris; Jeanette Schwarz; Ian Galea; Holger Jon Møller; Søren Kragh Moestrup
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.